Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
Sanara MedTech
SMTI
$315M
| $251K | ﹤0.01% |
8,853
+4,442
| +101% | +$133K |
|
4052
PUT
Xerox
XRX
$407M
| $250K | ﹤0.01% |
47,500
| – | – |
|
4053
RE/MAX Holdings
RMAX
$261M
| $250K | ﹤0.01% |
30,564
+12,527
| +69% | +$97.2K |
|
4054
Medifast
MED
$130M
| $250K | ﹤0.01% |
17,788
+6,991
| +65% | +$91.9K |
|
4055
Santander
BSBR
$43.1B
| $250K | ﹤0.01% |
+45,798
| New | +$234K |
|
|
BNT
4056
Brookfield Wealth Solutions
BNT
$12.3B
| $249K | ﹤0.01% |
6,051
-60
| -1% | -$2.22K |
|
|
PLL
4057
DELISTED
Piedmont Lithium
PLL
| $249K | ﹤0.01% |
42,739
+18,344
| +75% | +$120K |
|
4058
Hurco Companies Inc
HURC
$142M
| $248K | ﹤0.01% |
13,118
+450
| +4% | +$6.79K |
|
4059
ProShares Short VIX Short-Term Futures ETF
SVXY
$233M
| $248K | ﹤0.01% |
5,810
| – | – |
|
|
ASIC
4060
Ategrity Specialty Insurance
ASIC
$1.2B
| $247K | ﹤0.01% |
+11,500
| New | +$263K |
|
4061
Invesco S&P 500 GARP ETF
SPGP
$2.31B
| $247K | ﹤0.01% |
2,297
| – | – |
|
4062
CPI Card Group
PMTS
$355M
| $247K | ﹤0.01% |
10,429
+4,953
| +90% | +$117K |
|
|
BFIN
4063
DELISTED
BankFinancial
BFIN
| $246K | ﹤0.01% |
21,295
+21,216
| +26,856% | +$253K |
|
4064
Avita Medical
RCEL
$243M
| $246K | ﹤0.01% |
46,559
+17,766
| +62% | +$129K |
|
4065
Larimar Therapeutics
LRMR
$446M
| $245K | ﹤0.01% |
84,860
+30,601
| +56% | +$70.8K |
|
|
TOPT
4066
iShares Top 20 U.S. Stocks ETF
TOPT
$675M
| $245K | ﹤0.01% |
8,986
| – | – |
|
4067
DocGo
DCGO
$64.1M
| $245K | ﹤0.01% |
156,132
+52,640
| +51% | +$98.1K |
|
4068
Inhibrx
INBX
$1.41B
| $245K | ﹤0.01% |
17,164
+3,881
| +29% | +$50.2K |
|
4069
ReNew
RNW
$2.48B
| $245K | ﹤0.01% |
35,440
+20,667
| +140% | +$135K |
|
|
LB
4070
LandBridge Co
LB
$2.17B
| $242K | ﹤0.01% |
3,585
+433
| +14% | +$31.2K |
|
4071
Omega Flex
OFLX
$307M
| $242K | ﹤0.01% |
7,481
+2,522
| +51% | +$81K |
|
4072
Copa Holdings
CPA
$5.57B
| $242K | ﹤0.01% |
+2,200
| New | +$217K |
|
4073
SB Financial Group
SBFG
$171M
| $242K | ﹤0.01% |
12,644
+12,304
| +3,619% | +$233K |
|
4074
Kimbell Royalty Partners
KRP
$1.5B
| $239K | ﹤0.01% |
17,120
+995
| +6% | +$13K |
|
4075
Pixelworks
PXLW
$38.8M
| $239K | ﹤0.01% |
34,179
-1
| -0% | -$6 |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.